Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intratumoral T cell depletion following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is associated with poor clinical outcome.
van Wilpe S, Sultan S, Gorris MAJ, Somford DM, Kusters-Vandevelde HVN, Koornstra RHT, Gerritsen WR, Simons M, van der Heijden AG, de Vries IJM, Mehra N. van Wilpe S, et al. Among authors: van der heijden ag. Cancer Immunol Immunother. 2023 Jan;72(1):137-149. doi: 10.1007/s00262-022-03234-0. Epub 2022 Jun 30. Cancer Immunol Immunother. 2023. PMID: 35771253 Free PMC article.
Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort study.
Richters A, Mehra N, Meijer RP, Boormans JL, van der Heijden AG, Smilde TJ, van der Heijden MS, Kiemeney LA, Aben KK. Richters A, et al. Among authors: van der heijden ag, van der heijden ms. Cancer Treat Res Commun. 2020;25:100266. doi: 10.1016/j.ctarc.2020.100266. Epub 2020 Dec 8. Cancer Treat Res Commun. 2020. PMID: 33316557 Free article.
Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the 'trials within cohorts' study ProBCI.
Richters A, Meijer RP, Mehra N, Boormans JL, van der Heijden AG, van der Heijden MS, Kiemeney LA, Aben KK. Richters A, et al. Among authors: van der heijden ag, van der heijden ms. BMJ Open. 2021 May 18;11(5):e047256. doi: 10.1136/bmjopen-2020-047256. BMJ Open. 2021. PMID: 34006553 Free PMC article.
Overall Survival of Patients Receiving Cisplatin or Carboplatin for Primary Metastatic Urothelial Carcinoma of the Bladder: A Contemporary Dutch Nationwide Cohort Study.
Richters A, Boormans JL, van der Heijden MS, van der Heijden AG, Meijer RP, Mehra N, Kiemeney LALM, Aben KKH. Richters A, et al. Among authors: van der heijden ms, van der heijden ag. Eur Urol Focus. 2022 Jul;8(4):995-1002. doi: 10.1016/j.euf.2021.08.009. Epub 2021 Sep 15. Eur Urol Focus. 2022. PMID: 34535437 Free article.
Optimization of Preoperative Lymph Node Staging in Patients with Muscle-Invasive Bladder Cancer Using Radiomics on Computed Tomography.
Starmans MPA, Ho LS, Smits F, Beije N, de Kruijff I, de Jong JJ, Somford DM, Boevé ER, Te Slaa E, Cauberg ECC, Klaver S, van der Heijden AG, Wijburg CJ, van de Luijtgaarden ACM, van Melick HHE, Cauffman E, de Vries P, Jacobs R, Niessen WJ, Visser JJ, Klein S, Boormans JL, van der Veldt AAM. Starmans MPA, et al. Among authors: van der veldt aam, van de luijtgaarden acm, van der heijden ag, van melick hhe. J Pers Med. 2022 Apr 30;12(5):726. doi: 10.3390/jpm12050726. J Pers Med. 2022. PMID: 35629148 Free PMC article.
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections.
van Puffelen JH, Novakovic B, van Emst L, Kooper D, Zuiverloon TCM, Oldenhof UTH, Witjes JA, Galesloot TE, Vrieling A, Aben KKH, Kiemeney LALM, Oosterwijk E, Netea MG, Boormans JL, van der Heijden AG, Joosten LAB, Vermeulen SH. van Puffelen JH, et al. Among authors: van emst l, van der heijden ag. J Immunother Cancer. 2023 Jan;11(1):e005518. doi: 10.1136/jitc-2022-005518. J Immunother Cancer. 2023. PMID: 36693678 Free PMC article.
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
van Dorp J, Pipinikas C, Suelmann BBM, Mehra N, van Dijk N, Marsico G, van Montfoort ML, Hackinger S, Braaf LM, Amarante T, van Steenis C, McLay K, Daletzakis A, van den Broek D, van de Kamp MW, Hendricksen K, de Feijter JM, Boellaard TN, Meijer RP, van der Heijden AG, Rosenfeld N, van Rhijn BWG, Jones G, van der Heijden MS. van Dorp J, et al. Among authors: van montfoort ml, van steenis c, van rhijn bwg, van den broek d, van de kamp mw, van der heijden ag, van der heijden ms, van dijk n. Nat Med. 2023 Mar;29(3):588-592. doi: 10.1038/s41591-022-02199-y. Epub 2023 Feb 2. Nat Med. 2023. PMID: 36732628 Clinical Trial.
92 results